• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Vivo Bio Tech Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 3920.0
  • ISIN : INE380K01017
33.20 0 (0.00%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    32.31

  • Today’s High

    33.85

  • Open

    33.85

  • Perv Close

    33.20

  • 52W Low

    31.20

  • 52W High

    56.90

Key Indicators

  • P/E(TTM)

    8.06

  • Mar.Cap (₹Cr.)

    61.02

  • Div & Yield %

    0.00

  • Book Value(₹)

    41.56

  • Debt-Equity Ratio

    0.00

  • AGM Date

    01-Aug-2025

  • EPS

    4.12

  • P/E Ratio

    8.06

Financials Ratios

  • Debt-Equity Ratio

    1.27

  • Mar.Cap (₹Cr.)

    61.02

  • RONW (%)

    4.76

  • ROCE (%)

    9.88

Score Board

  • Equity (₹ in Cr.)

    18.38

  • BV (₹)

    41.60

  • Sales( ₹ in Cr.)

    46.67

  • NP (in Cr.)

    7.57

  • NP Var(%)

    200.0

  • Div%

    0.0

  • CPS (₹)

    9.00

  • EPS (₹)

    4.10

  • Traded Value (₹ in Lakhs)

    61.02

  • 52 Week High

    56.90

  • 52 Week Low

    31.20

  • Price BSE

    33.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    61.02

  • P/C Ratio

    3.70

  • P/E Ratio

    8.00

  • Price Vs.BV

    4.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 44.88 51.62 51.39 51.78 55.35 55.83
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 44.88 51.62 51.39 51.78 55.35 55.83
Other Income 0.04 0.04 0.09 0.08 0.05 0.01
Stock Adjustments 0.80 -1.84 -3.47 2.70 2.34 0.65
Total Income 45.72 49.82 48.01 54.56 57.74 56.49
EXPENDITURE :            
Raw Materials 4.65 4.93 7.97 9.91 10.90 12.41
Power and Fuel Cost 3.93 4.27 3.56 5.78 4.69 2.93
Employee Cost 10.13 13.15 9.42 8.57 10.00 9.58
Other Manufacturing Expenses 1.68 2.56 3.03 1.42 4.50 5.79
Selling and Administration Expenses 4.01 3.05 7.76 11.02 6.93 9.53
Miscellaneous Expenses 0.02 0.00 0.10 -0.02 8.21 6.73
Employee Benefit Expenses 10.13 13.15 9.42 8.57 10.00 9.58
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 24.43 27.96 31.83 36.67 45.22 46.97
Operating Profit 21.30 21.86 16.18 17.88 12.53 9.52
Interest 7.95 7.99 4.27 3.67 3.10 2.64
Gross Profit 13.35 13.87 11.91 14.21 9.43 6.88
Depreciation 9.29 9.27 7.44 5.59 5.17 5.06
Profit Before Tax 4.06 4.60 4.47 8.62 4.26 1.82
Current Tax 1.68 1.03 0.76 1.36 1.12 0.38
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.14 0.94 1.51 1.58 -1.31 -0.80
Reported Net Profit 2.52 2.63 2.20 5.68 4.44 2.25
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit 2.52 2.63 2.20 5.68 4.44 2.25
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 18.98 16.35 14.15 8.46 4.02 1.77
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 21.51 18.98 16.35 14.15 8.46 4.02
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 1.69 1.77 1.54 4.24 3.45 1.82
Earnings Per Share(Adj)-Unit Curr 1.69 1.77 1.54 4.24 3.45 1.82
Book Value 36.50 34.81 32.57 30.64 25.63 21.85
Book Value(Adj)-Unit Curr 36.50 34.81 32.57 30.64 25.63 21.85

Shareholding Pattern

  • Promoter Group

    39.06%

  • Public Share Holding

    60.94%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 5,812,000 29.22 5,812,000 6
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,959,500 9.85 459,500 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 7,771,500 39.06 6,271,500 11
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 3,506,614 17.63 1,233,385 47
Clearing Members 100 0.00 100 1
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 361,724 1.82 361,724 87
Foreign Non Institution Other 1,412,975 7.10 112,975 2
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 2,355,734 11.84 2,280,734 47
Individuals holding nominal share capital up to Rs. 1 lakh 4,485,242 22.55 4,254,455 21,670
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 12,122,389 60.94 8,243,373 21,854
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 19,893,889 100.00 14,514,873 21,865

Company Background

Vivo Bio Tech LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Vivo Bio Tech Ltd
  • BSE Code : 3920.0
  • ISIN : INE380K01017

  • Incorporation Year

    1987

  • Registered Office

    Survey #349/A Pregnapur Vlge
    , Gajel,
    Telangana-502311

  • Telephone

  • FAX

  • Chairman

  • Managing Director

  • Company Secretary

    A V Kiran

  • Auditor

    P Murali & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Aarthi Consultants Pvt Ltd
    1-2-285,
    Domalguda,J B Apartments
    Mumbai - Hyderabad - 500 029

Vivo Bio Tech Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Vivo Bio Tech 33.20 44.92 44.88 8.06 10.06
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10